levetiracetam
Commercial- Indications
- Epilepsy
Company intelligence / Profile preview
Aprecia Pharmaceuticals
Blue Ash, Ohio, United Statesaprecia.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Aprecia Pharmaceuticals pioneered the use of three-dimensional printing to manufacture pharmaceuticals. Its ZipDose® technology enables high-dose, rapidly disintegrating oral tablets that are easy to swallow. The company’s lead product, Spritam® (levetiracetam), was the first FDA-approved drug made with this method. Clinical results show Spritam provides a patient-friendly alternative for those with swallowing difficulties. The company has validated its process through approval and commercial launch of Spritam®, with additional products leveraging its proprietary platforms in late-stage planning.
- Therapeutic areas
- Neurology
- Modalities
- Oral fast-melt tablets (ZipDose® technology)Orodispersible tabletsSublingual/Buccal tabletsModified release formulationsCombination therapiesHigh-dose and ultra-low dose oral drugs
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Glatt Pharmaceutical Serviceslicensing partnerships with pharma companies to extend product lines using ZipDose technology
Beyond the preview
Go deeper on Aprecia Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aprecia Pharmaceuticals.